These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


366 related items for PubMed ID: 8294096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA, Liao Y, An JK, Muglia LJ, Perlmutter DH, Teckman JH.
    Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study.
    Francalanci P, Santorelli FM, Saccani S, Bonetti MF, Medicina D, Coni P, Faa G, Callea F.
    Liver Int; 2009 Nov; 29(10):1593-6. PubMed ID: 19744266
    [Abstract] [Full Text] [Related]

  • 7. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
    Rudnick DA, Shikapwashya O, Blomenkamp K, Teckman JH.
    Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
    [Abstract] [Full Text] [Related]

  • 8. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Perlmutter DH.
    Pediatr Res; 2006 Aug; 60(2):233-8. PubMed ID: 16864711
    [Abstract] [Full Text] [Related]

  • 9. Transgenic mouse models of hepatocellular carcinoma.
    Gordon JW.
    Hepatology; 1994 Feb; 19(2):538-9. PubMed ID: 8294111
    [No Abstract] [Full Text] [Related]

  • 10. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man].
    van den Hazel SJ, Meijer JW, van den Elshout FJ, de Vries RA.
    Ned Tijdschr Geneeskd; 2000 Nov 18; 144(47):2269-72. PubMed ID: 11109473
    [Abstract] [Full Text] [Related]

  • 11. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice.
    Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, Kurokawa K.
    Hepatology; 1994 Apr 18; 19(4):810-9. PubMed ID: 8138251
    [Abstract] [Full Text] [Related]

  • 12. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS.
    Am J Pathol; 1996 Aug 18; 149(2):407-28. PubMed ID: 8701981
    [Abstract] [Full Text] [Related]

  • 13. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.
    Dunsford HA, Sell S, Chisari FV.
    Cancer Res; 1990 Jun 01; 50(11):3400-7. PubMed ID: 1692259
    [Abstract] [Full Text] [Related]

  • 14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug 01; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 15. alpha 1-Antitrypsin deficiency and hepatocellular carcinoma. Association with cirrhosis, copper storage, and Mallory bodies.
    Rubel LR, Ishak KG, Benjamin SB, Knuff TE.
    Arch Pathol Lab Med; 1982 Dec 01; 106(13):678-81. PubMed ID: 6291490
    [Abstract] [Full Text] [Related]

  • 16. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T, Hino K, Okuda M, Gondo T, Nishina S, Kitase A, Korenaga M, Xiao SY, Weinman SA, Lemon SM, Sakaida I, Okita K.
    Gastroenterology; 2006 Jun 01; 130(7):2087-98. PubMed ID: 16762631
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease.
    Rudnick DA, Perlmutter DH.
    Hepatology; 2005 Sep 01; 42(3):514-21. PubMed ID: 16044402
    [Abstract] [Full Text] [Related]

  • 19. Development of liver tumors in transforming growth factor alpha transgenic mice.
    Lee GH, Merlino G, Fausto N.
    Cancer Res; 1992 Oct 01; 52(19):5162-70. PubMed ID: 1327502
    [Abstract] [Full Text] [Related]

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 01; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.